韦志超 首席经济学家 SAC 执证编号：S0110520110004 weizhichao@sczq.com.cn 电话：86-10-81152692 [Table_Authors] [Table_Summary] [Table首_O创th证erR券ep宏or观t]经济分析报告：美联 储决策迷雾未散，市场波动加大 社融数据不及预期 首创证券宏观经济分析报告：AI 分 歧加剧，仍需边走边看 2 月我国 CPI 同比录得+1.3%，高于 Wind 一致预期+0.88%，较前值提 高 1.1pct，CPI 环比上涨 1%。2 月我国 PPI 同比录得-0.9%，高于 Wind 一致预期-1.16%，较前值提高 0.5pct，PPI 环比上涨 0.4%。 相关研究 首创证券周报：消费股表现回暖， 服务消费热度与金价支撑 2 月 CPI 环比超预期。2 月食品烟酒 CPI 环比 录得+1.4%，较前值提高 1.4pct，主要受春节假期影响，其中水产品价 格环比增长 6.9%，酒类和烟草价格分别环比录得-1.1%和-0.1%。2 月核 心 CPI 同比录得+1.8%，较前值提高 1pct，受春节错位和假期时长增加 影响， ...

Investment Rating - The investment rating for the company is "Buy" [1] Core Insights - The company reported a revenue of 24.98 billion yuan for 2025, representing a year-on-year growth of 4.06%, while the net profit attributable to shareholders decreased by 16.5% to 3.21 billion yuan [2][5] - The company plans to distribute a cash dividend of 11 yuan per 10 shares, totaling 1.283 billion yuan, which reflects an increase in the dividend payout ratio to 76% for 2025 [5] - The company experienced a decline in profit due to the ramp-up phase of new factories and adjustments in production capacity, but profitability is expected to recover as new customer orders increase and old customer orders stabilize [5] Financial Performance Summary - Revenue projections for the company are as follows: 2024A at 24.006 billion yuan, 2025E at 24.980 billion yuan, 2026E at 27.018 billion yuan, and 2027E at 29.545 billion yuan, with growth rates of 19.4%, 4.1%, 8.2%, and 9.4% respectively [3] - The net profit attributable to shareholders is projected to be 3.84 billion yuan in 2024, decreasing to 3.21 billion yuan in 2025E, and then increasing to 3.717 billion yuan in 2026E and 4.238 billion yuan in 2027E [3] - The company's earnings per share (EPS) is expected to be 3.29 yuan in 2024, dropping to 2.75 yuan in 2025E, and then recovering to 3.18 yuan in 2026E and 3.63 yuan in 2027E [3] Market and Operational Insights - The company’s sales volume for athletic shoes in 2025 was 227 million pairs, a year-on-year increase of 1.59%, with an average selling price of approximately 110 yuan, reflecting a 2.4% increase [5] - The company faced challenges in Q4 2025, with a revenue decline of 3% and a net profit drop of 22.7% compared to the previous year [5] - The company has successfully ramped up production in three new factories, contributing to profitability despite the overall pressure on margins [5]

Investment Rating - The investment rating for the company is "Buy" [1] Core Insights - The company plans to acquire a 29.06% stake in Puma for €1.506 billion (approximately RMB 12.28 billion), becoming Puma's largest shareholder [1] - Puma is currently undergoing a strategic adjustment phase, with expected long-term investment returns [4] - The acquisition price represents a 62% premium based on Puma's stock price as of January 26, 2026, indicating a strong long-term brand value despite short-term profitability challenges [4] - The company is focusing on a multi-brand strategy and global expansion, leveraging its experience to enhance Puma's profitability and support its own international business development [4] Financial Summary - The company's main business revenue is projected to grow from RMB 70.826 billion in 2024 to RMB 94.095 billion in 2027, with a compound annual growth rate (CAGR) of approximately 8.7% [2] - The net profit attributable to shareholders is expected to decrease from RMB 156.0 billion in 2024 to RMB 131.5 billion in 2025, before recovering to RMB 162.2 billion in 2027 [2] - The earnings per share (EPS) is forecasted to decline from RMB 5.52 in 2024 to RMB 4.66 in 2025, then gradually increase to RMB 5.74 by 2027 [2] - The price-to-earnings (PE) ratio is projected to be 16 in 2025, 15 in 2026, and 13 in 2027, reflecting a favorable valuation trend [2] Market Performance - The company's stock price has fluctuated between HKD 107.5 and HKD 65.6 over the past year, with a current price of HKD 85.3 [1] - The company's market capitalization stands at HKD 240.8 billion [1]

Investment Rating - The industry investment rating is "Positive" [1] Core Insights - The National Healthcare Security Administration issued a guideline on January 20, 2026, for pricing projects related to surgical and therapeutic auxiliary medical services, which is expected to enhance the penetration rate of surgical robots [5] - The guideline consolidates existing pricing projects into 37 items and aims to standardize pricing across provinces, facilitating the promotion of precision medical technologies in clinical settings [5] - The pricing structure for surgical robots includes three tiers based on their involvement in surgeries, which is anticipated to increase their usage in complex procedures [5] - Domestic surgical robot companies with significant surgical volume and clinical recognition are expected to benefit from industry expansion, including companies like Tianzhihang-U, Aikang Medical, Weikang Robot, and Jingfeng Medical [5] Summary by Sections Market Trends - The report highlights a recent trend in the medical and biological sector, indicating a slight decline in the market index over the past year, with a notable focus on surgical robots [2] Industry Developments - The guideline's focus on various advanced medical technologies, such as 3D printing and robotic-assisted surgeries, is expected to clarify and unify pricing standards, thereby enhancing the market acceptance of domestic surgical robots [5] Company Performance - Key companies in the surgical robot industry are showing promising operational metrics, with Tianzhihang performing over 35,000 surgeries and holding a market share exceeding 70% in domestic orthopedic robot surgeries [6] - Aikang Medical anticipates a revenue growth of approximately 110% to 120% in 2025, driven by breakthroughs in the commercialization of its robotic products [6] - Weikang Robot has reported a fivefold increase in overseas market sales compared to the previous year, indicating strong growth potential [6] - Jingfeng Medical has expanded its product reach to over 20 countries, with significant operational milestones achieved [6]

Investment Rating - The industry investment rating is "Positive" [1][34] Core Insights - TSMC has raised its five-year compound growth rate forecast for the AI sector, indicating strong demand in the global AI field [5][9] - TSMC's revenue for Q4 2025 reached $33.73 billion, a year-on-year increase of 25.5%, with a gross margin of 62.3% [5][6] - The semiconductor sector is expected to continue its growth trajectory, with TSMC projecting a nearly 30% revenue increase for 2026 [9] Summary by Sections TSMC Performance - TSMC's revenue for Q4 2025 was $33.73 billion, with a gross margin of 62.3%, reflecting improvements in cost and capacity utilization [5][6] - The high-performance computing segment saw a 48% year-on-year growth in 2025, making it the fastest-growing application area [6][9] Capital Expenditure - TSMC plans to increase its capital expenditure for 2026 to between $52 billion and $56 billion, with a focus on advanced technology [8][9] - The capital budget will allocate approximately 70%-80% for advanced processes and 10%-20% for advanced packaging and testing [8] Market Performance - From January 12 to January 16, the electronic sector outperformed the market, with a 3.77% increase compared to a 0.45% decline in the Shanghai Composite Index [12][18] - The semiconductor sub-sector rose by 5.33% during the same period, indicating strong market interest [18][20] Investment Recommendations - The report suggests a focus on the global data center supply chain and recommends companies such as Industrial Fulian, Shenghong Technology, and SMIC [27]

Investment Rating - The investment rating for the company is "Accumulate" [2] Core Insights - The company has signed a cooperation agreement with Shangde Pharmaceutical to obtain exclusive commercialization rights for ACT001 in China and Southeast Asia, targeting small cell lung cancer brain metastases. ACT001 is the first drug globally targeting both STAT3 and NF-κB, showing significant clinical value and a high probability of market approval [4] - The core innovative drug, Yilishu®, is expected to continue its rapid growth, with projected cumulative shipments exceeding 500,000 units by 2025, representing a year-on-year increase of over 80%. The updated medical insurance directory expands the patient population eligible for reimbursement, which is beneficial for future sales growth [4] - The company anticipates significant revenue growth, with projected revenues of 54.15 billion yuan, 61.33 billion yuan, and 69.50 billion yuan for 2025, 2026, and 2027 respectively, reflecting year-on-year growth rates of 5.0%, 13.3%, and 13.3%. Net profits are expected to reach 5.21 billion yuan, 7.65 billion yuan, and 10.14 billion yuan during the same period, with growth rates of 35.0%, 47.0%, and 32.5% [4][6] Summary by Relevant Sections Company Overview - The latest closing price is 12.77 yuan, with a market capitalization of 155.33 billion yuan and a current P/E ratio of 38.13 [2] Financial Projections - Revenue projections for 2025, 2026, and 2027 are 54.15 billion yuan, 61.33 billion yuan, and 69.50 billion yuan, with corresponding net profits of 5.21 billion yuan, 7.65 billion yuan, and 10.14 billion yuan [6] - The expected EPS for 2025, 2026, and 2027 is 0.43 yuan, 0.63 yuan, and 0.83 yuan respectively [6] Market Position - The company is positioned to leverage its established sales network for the commercialization of ACT001, which has received multiple overseas qualifications and is undergoing pivotal clinical trials [4] - The innovative drug Yilishu® is set to benefit from an expanded patient base due to changes in the medical insurance reimbursement criteria, enhancing its market potential [4]

Investment Rating - The report rates the textile and apparel industry as "Positive" [1] Core Insights - The textile and apparel sector has underperformed the market, with a year-to-date increase of 12%, lagging behind the CSI 300 index by 4.1 percentage points, ranking 18th among 31 first-level industries [4][10] - The apparel and home textile segment has seen an 11.3% increase, while the textile manufacturing segment rose by 9.6%, and the accessories segment outperformed with a 17.4% increase [4][10] - The report highlights a potential recovery in demand for textile manufacturing due to stable domestic consumption and a resilient export market, particularly in the U.S. [4][19] - The sleep economy is expanding rapidly, driven by increasing health awareness and consumer spending on sleep-related products [4][63] - The gold and jewelry sector faces short-term demand suppression due to rising gold prices, but consumer spending on gold jewelry remains strong [4][63] Summary by Sections Market Overview - The textile and apparel sector has a TTM price-to-earnings ratio of 27.48, above the historical average since January 2020 [4][14] - The apparel and home textile segment has a TTM P/E ratio of 29.07, while the textile manufacturing segment stands at 23.9, and the accessories segment at 30.27, all above historical averages [4][14] Textile Manufacturing - Raw material prices are at historical lows, with cotton and synthetic fiber prices declining, while Australian wool prices have recently increased [4][19] - Domestic retail sales are showing steady growth, with apparel sales experiencing a slight recovery [4][30] - Export performance is affected by fluctuating tariffs and weak external demand, with a 4.4% year-on-year decline in apparel exports from January to November [4][43] Apparel and Home Textiles - The sleep economy is projected to grow significantly, with the market size expected to exceed 500 billion yuan in 2024, driven by increased consumer awareness and spending on sleep health products [4][66] - The outdoor sports market is also expanding, with a trend towards specialization and segmentation, supported by rising consumer income levels [4][63] Gold and Jewelry - Gold prices have surged over 50% this year, temporarily suppressing demand for gold jewelry, but overall consumer budgets for gold jewelry are increasing [4][63] - The report notes that consumer preferences are shifting towards lighter and more innovative gold products, with a focus on craftsmanship and cultural connections [4][63] Investment Strategy - The report recommends investing in leading companies with strong barriers in production capacity, technology, and customer relationships within the textile manufacturing sector, such as Shenzhou International and Huayi Group [4][63] - For the apparel and home textile sector, it suggests focusing on high-growth segments related to the sleep economy and outdoor sports [4][63]

Group 1: Economic Policy Adjustments - The 2025 Central Economic Work Conference has shifted its focus from "nine tasks" in 2024 to "eight tasks," emphasizing the importance of domestic demand as the primary driver of economic growth[9] - The task of expanding domestic demand has been elevated to the top priority, with a focus on "building a strong domestic market" and implementing specific actions to boost consumption and income[10] - The urgency of risk prevention has decreased, with the task of "preventing and resolving key area risks" moving from fifth to eighth place, indicating progress in areas like debt replacement and real estate[9] Group 2: Investment and Consumption Strategies - The conference emphasizes the integration of investment in both physical assets and human capital, with a focus on enhancing income for all urban and rural residents through specific plans[10] - Service consumption is highlighted as a key area for expanding domestic demand, with the service sector showing higher multiplier effects and lower risks compared to traditional goods consumption[25] - The government aims to stabilize the real estate market by encouraging the purchase of existing homes for affordable housing, which is expected to alleviate liquidity pressures on real estate companies[38] Group 3: Financial and Monetary Policies - The fiscal policy will maintain necessary levels of fiscal deficit, total debt, and expenditure, focusing on optimizing the expenditure structure for greater policy effectiveness[15] - Monetary policy will continue to be moderately accommodative, with an emphasis on promoting stable economic growth and reasonable price recovery, while ensuring liquidity remains ample[21] - The total social financing (TSF) increased by 33.4 trillion yuan in the first eleven months of the year, reflecting a 13.6% year-on-year increase, indicating strong financial support for the real economy[27] Group 4: Long-term Economic Outlook and Risks - The macroeconomic outlook remains positive, with structural reforms expected to deepen, focusing on quality improvement and effective growth[60] - Risks include potential delays in policy implementation and effectiveness, external economic pressures, and market and credit risks that could impact domestic asset prices[61]

Production - In November, the industrial added value of large-scale industrial enterprises increased by 4.8% year-on-year, with high-tech industries contributing 29.8% to the overall growth[9] - The service production index recorded a year-on-year increase of 4.2% in November, showing a slight decline from October[21] - The growth rate of traditional manufacturing industries is under pressure, while some technology-intensive manufacturing sectors maintain high growth rates[18] Investment - From January to November, fixed asset investment showed a cumulative year-on-year decline of 2.6%, the lowest since July 2020, down 0.9 percentage points from the previous month[10] - Manufacturing investment growth has slowed for eight consecutive months, with a cumulative year-on-year increase of 1.9%[23] - Real estate investment saw a year-on-year decline of 16%, with both supply and demand sides under pressure[38] Consumption - In November, the retail sales of consumer goods increased by only 1.3% year-on-year, falling short of the expected 2.93%[11] - The retail growth of building and decoration materials dropped to -17%, the lowest since March 2020, due to high base effects and cautious expectations[57] - Policies to stimulate consumption are expected to be implemented, focusing on enhancing consumer confidence and optimizing related systems[76] Risks - Risks include potential underperformance of policy implementation, external demand fluctuations, and weak recovery in resident consumption[78] - The real estate market faces adjustment risks, which could indirectly impact infrastructure investment and related consumption sectors[78]

Investment Rating - The investment rating for the company is "Buy" [1] Core Insights - The company specializes in high-end PCB manufacturing and is positioned in the core AI computing sector [2] - The company has a strong market presence, ranking sixth globally and third among domestic PCB manufacturers in China [5] - The company has achieved significant revenue growth driven by AI demand, with a projected revenue of 198.79 billion yuan in 2025, representing an 85.24% increase from the previous year [3][5] - The company is expanding its production capacity to meet the growing demand for high-end PCBs, particularly in AI applications [5] Financial Performance - The company reported a revenue of 141.17 billion yuan for the first three quarters of 2025, a year-on-year increase of 83.40% [5] - The net profit for the same period was 32.45 billion yuan, reflecting a year-on-year growth of 324.38% [5] - The gross margin for the first three quarters of 2025 was 35.85%, and the net margin was 22.98% [5] Revenue Forecast - Revenue projections for the company are as follows: - 2024: 107.31 billion yuan - 2025: 198.79 billion yuan - 2026: 333.64 billion yuan - 2027: 497.31 billion yuan [3] - The corresponding net profit forecasts are: - 2024: 11.54 billion yuan - 2025: 49.47 billion yuan - 2026: 91.58 billion yuan - 2027: 137.48 billion yuan [3] Market Outlook - The PCB market in China is expected to grow significantly, with an estimated increase of 8.5% in 2025 [5] - High-layer PCBs are projected to grow by 69.4%, while HDI boards are expected to increase by 14.2% [5] - The overall PCB market size is forecasted to grow from 73.565 billion USD in 2024 to 94.661 billion USD by 2029, with a compound annual growth rate of 5.2% [5]